Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to $13.5 million.

  • GoHealth's Amortization of Deferred Charges rose 34585.95% to $13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year increase of 25665.19%. This contributed to the annual value of $9.0 million for FY2024, which is 18003.75% up from last year.
  • As of Q3 2025, GoHealth's Amortization of Deferred Charges stood at $13.5 million, which was up 34585.95% from $12.8 million recorded in Q2 2025.
  • In the past 5 years, GoHealth's Amortization of Deferred Charges registered a high of $13.5 million during Q3 2025, and its lowest value of $434000.0 during Q3 2021.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $791000.0 (2023), whereas its average is $2.3 million.
  • Per our database at Business Quant, GoHealth's Amortization of Deferred Charges plummeted by 7835.39% in 2021 and then surged by 34585.95% in 2025.
  • Quarter analysis of 5 years shows GoHealth's Amortization of Deferred Charges stood at $526000.0 in 2021, then soared by 39.35% to $733000.0 in 2022, then grew by 9.0% to $799000.0 in 2023, then skyrocketed by 104.13% to $1.6 million in 2024, then soared by 728.57% to $13.5 million in 2025.
  • Its last three reported values are $13.5 million in Q3 2025, $12.8 million for Q2 2025, and $998000.0 during Q1 2025.